Clinical Trials · NCT00108355

Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis

CompletedPhase 4Octreotide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
US Department of Veterans Affairs
Enrollment
29
Start date
Dec 2003
Locations
1 site, United States
Primary endpoint
Time to Recurrence of Ascites.
View Octreotide compound reference